These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38533136)

  • 1. Association of Inflammatory Markers With Disease Progression and the Severity of COVID-19.
    Patel SV; Pathak JM; Parikh RJ; Pandya KJ; Kothari PB; Patel A
    Cureus; 2024 Feb; 16(2):e54840. PubMed ID: 38533136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Hassan M; Rasheed U; Ahmed Khan S
    Cureus; 2020 Aug; 12(8):e9575. PubMed ID: 32913691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital.
    Sukrisman L; Sinto R
    J Int Med Res; 2021 Nov; 49(11):3000605211059939. PubMed ID: 34796762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Lung Injury Biomarkers in the Prediction of COVID-19 Severity: Total Thiol, Ferritin and Lactate Dehydrogenase.
    Martinez Mesa A; Cabrera César E; Martín-Montañez E; Sanchez Alvarez E; Lopez PM; Romero-Zerbo Y; Garcia-Fernandez M; Velasco Garrido JL
    Antioxidants (Basel); 2021 Jul; 10(8):. PubMed ID: 34439469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of COVID-19 Real-Time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Cycle Threshold Value With Surrogate Markers of Disease Severity.
    John JE; Amle DB; Takhelmayum R; Gopal N; Mishra M; Joshi P; Rathod B; Gadkari R
    Cureus; 2022 Nov; 14(11):e31034. PubMed ID: 36475201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.
    Saeed MAM; Mohamed AH; Owaynat AH
    Egypt J Intern Med; 2022; 34(1):19. PubMed ID: 35194371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of Psychosocial Manifestations and Quality of Life With Inflammatory Markers in SARS-CoV-2 Patients: A Study From a Dedicated COVID-19 Tertiary Care Hospital.
    Kumar K; Srivastava S; Meena A; Avasthi RK; Kashyap B
    Cureus; 2023 Jul; 15(7):e42341. PubMed ID: 37621784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Value of C-reactive Protein, Lactate Dehydrogenase, Ferritin and D-dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study.
    Kaftan AN; Hussain MK; Algenabi AA; Naser FH; Enaya MA
    Acta Inform Med; 2021 Mar; 29(1):45-50. PubMed ID: 34012213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
    Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
    PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.
    Sahin O; Aktoz F; Bagci H; Vurgun E
    J Obstet Gynaecol; 2022 Aug; 42(6):1917-1921. PubMed ID: 35603633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2.
    De Rop L; Bos DA; Stegeman I; Holtman G; Ochodo EA; Spijker R; Otieno JA; Alkhlaileh F; Deeks JJ; Dinnes J; Van den Bruel A; McInnes MD; Leeflang MM; ; Verbakel JY
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015050. PubMed ID: 39105481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between vitamin D level and severity of prognostic markers in Egyptian COVID-19 patients: a cohort study.
    Ramadan H; Shennawy AM
    Egypt J Intern Med; 2022; 34(1):49. PubMed ID: 35754946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed Tomography Severity Scoring on High-Resolution Computed Tomography Thorax and Inflammatory Markers With COVID-19 Related Mortality in a Designated COVID Hospital.
    Ravindra Naik B; Sakalecha AK; B N S; A C; Kale R M; Uhasai K
    Cureus; 2022 Apr; 14(4):e24190. PubMed ID: 35592193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
    Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
    Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.